⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10142369 | 0.94 | — | — | |
| SCHEMBL10142363 | 0.91 | — | — | |
| SCHEMBL10142784 | 0.91 | TMPRSS2 (0.31) | — | |
| SCHEMBL14845667 | 0.91 | TMPRSS2 (0.31) | — | |
| SCHEMBL10142406 | 0.91 | CYP3A4 (0.32) | — | |
| SCHEMBL15257115 | 0.90 | CYP3A4 (0.42) | — | |
| SCHEMBL10142785 | 0.86 | TMPRSS2 (0.31) | — | |
| SCHEMBL19650099 | 0.85 | TMPRSS2 (0.31) | — | |
| SCHEMBL10142317 | 0.85 | CYP3A4 (0.37) | — | |
| SCHEMBL10142333 | 0.85 | CYP3A4 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8415308-B2 | 1′-substituted-carba-nucleoside prodrugs for antiviral treatment | GILEAD SCIENCES, INC. (US) | 2013-04-09 | — | — | US | disclosed |
| US-20120020921-A1 | 1'-SUBSTITUTED-CARBA-NUCLEOSIDE PRODRUGS FOR ANTIVIRAL TREATMENT | GILEAD SCIENCES, INC. (US) | 2012-01-26 | — | — | US | disclosed |